Prospera Financial Services’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8
| Closed | -$10K | – | 2041 |
|
|
2022
Q1 | $10K | Buy |
+8
| New | +$10K | ﹤0.01% | 2034 |
|
|
2021
Q4 | – | Sell |
-30
| Closed | -$46K | – | 883 |
|
|
2021
Q3 | $46K | Hold |
30
| – | – | ﹤0.01% | 788 |
|
|
2021
Q2 | $60K | Sell |
30
-1
| -3% | -$2K | ﹤0.01% | 782 |
|
|
2021
Q1 | $58K | Sell |
31
-8
| -21% | -$15K | ﹤0.01% | 736 |
|
|
2020
Q4 | $86K | Buy |
+39
| New | +$86K | 0.01% | 663 |
|
|
2020
Q3 | – | Sell |
-34
| Closed | -$97K | – | 1646 |
|
|
2020
Q2 | $97K | Sell |
34
-1
| -3% | -$2.85K | 0.01% | 561 |
|
|
2020
Q1 | $62K | Buy |
35
+22
| +169% | +$39K | 0.01% | 502 |
|
|
2019
Q4 | $70K | Buy |
+13
| New | +$70K | 0.01% | 587 |
|
|
2019
Q2 | – | Hold |
0
| – | -$4K | – | 522 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 321 |
|
|
2018
Q3 | – | Hold |
0
| – | -$26K | – | 425 |
|
|
2018
Q2 | – | Hold |
0
| – | -$38K | – | 446 |
|
|
2018
Q1 | – | Hold |
0
| – | -$57K | – | 436 |
|
|
2017
Q4 | – | Hold |
0
| – | -$126K | – | 387 |
|
|
2017
Q3 | – | Hold |
0
| – | -$99K | – | 411 |
|
|
2017
Q2 | – | Hold |
0
| – | -$287K | – | 410 |
|
|
2017
Q1 | – | Hold |
0
| – | -$236K | – | 274 |
|
|
2016
Q4 | – | Hold |
0
| – | -$207K | – | 315 |
|
|
2016
Q3 | – | Hold |
0
| – | -$186K | – | 345 |
|
|
2016
Q2 | – | Hold |
0
| – | -$215K | – | 326 |
|
|
2016
Q1 | – | Hold |
0
| – | -$140K | – | 288 |
|
|
2015
Q4 | – | Hold |
0
| – | -$181K | – | 279 |
|
|
2015
Q3 | – | Hold |
0
| – | -$69K | – | 265 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 293 |
|